Research Coordination and Capacity-building Objectives

The main objective of AMiCI action is to develop, structure, coordinate and maintain a long-term, flexible and open European network in the field of AMC in healthcare. The scientific field encompasses R&D of materials and coatings, testing, legal aspects and cleaning methods. Research coordination will not only include knowledge institutes, such as universities and applied science institutes, but will also incorporate producers, distributors, processors, policy

Rising threats from AntiMicriobial Resistance

Many efforts to reduce AMR have been initiated, are ongoing and have been concluded. However many of these have been proven to be only partially sufficient. In order to succeed, a holistic approach is needed (Communication from the Commission to the European Parliament and the Council – Action plan against the rising threats from Antimicrobial Resistance). AMR is a major European and global societal problem,

AMiCI Action in Relation to Existing Efforts at European Level

Coordination of the best European research resources and capabilities will form the necessary critical mass and develop the most advanced scientific approaches to tackle AMR, reversing its increasing trend, and leading to the sustainable use of antibiotics and treatments for infectious diseases. In this context, the networking efforts of AMICI provide an important link to the EC’s Joint Programming Initiative (JPI) on AMR. This connection

The state-of-the-art in AMC

Novel antibiotic drugs are scarce and increasing resistance against antimicrobial drugs is established. Innovations that tackle rising and prominent threats in healthcare are demanded. Preventive innovations are needed to minimize microbial pressure in bacterial “hotspots”, like hospitals, nursing homes or day-care centres. For example, bacteria can persist for many months on inanimate surfaces, forming an ongoing source of transmission. Healthcare workers can transfer these microbes